Abstract
In past decades, a rapid evolution of diabetes technology led to increased popularity and use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) in the ambulatory setting for diabetes management, and recently, the artificial pancreas became available. Efforts to translate this technology to the hospital setting have shown accuracy and reliability of CGM, safety of CSII in appropriate populations, improvement of inpatient glycemic control with computerized glycemic management systems, and feasibility of inpatient CGM-CSII closed-loop systems. Several ongoing studies are focusing on continued translation of this technology to improve glycemic control and outcomes in hospitalized patients.
Keywords:
Diabetes; Glycemic control; Hospital; Inpatient; Technology.
Copyright © 2019 Elsevier Inc. All rights reserved.
Publication types
-
Historical Article
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Blood Glucose / analysis
-
Blood Glucose Self-Monitoring / history
-
Blood Glucose Self-Monitoring / instrumentation
-
Blood Glucose Self-Monitoring / trends
-
Diabetes Mellitus / blood
-
Diabetes Mellitus / drug therapy
-
Diabetes Mellitus / history
-
Diabetes Mellitus / therapy*
-
History, 20th Century
-
History, 21st Century
-
Hospitalization* / trends
-
Humans
-
Hyperglycemia / blood
-
Hyperglycemia / drug therapy
-
Hyperglycemia / history
-
Hyperglycemia / therapy*
-
Inpatients
-
Insulin / administration & dosage
-
Insulin Infusion Systems / history
-
Insulin Infusion Systems / supply & distribution
-
Insulin Infusion Systems / trends
-
Inventions* / history
-
Inventions* / trends
-
Pancreas, Artificial / history
-
Pancreas, Artificial / supply & distribution